Point Biopharma nets NRC OK to operate facility in Ind.

By AuntMinnie.com staff writers

April 28, 2021 -- Point Biopharma has received a materials license from the U.S. Nuclear Regulatory Commission (NRC) for its new radioligand manufacturing facility in Indianapolis, IN.

The license authorizes the radiopharmaceutical company to begin handling nuclear material at the 80,000-sq-ft facility, which is almost completely renovated. The license enables Point to begin working onsite with radioisotopes such as lutetium-177 and actinium-225 and complete testing and qualification of the facility.


Copyright © 2021 AuntMinnie.com
 

To read this and get access to all of the exclusive content on AuntMinnie.com create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a AuntMinnie.com password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking
account: